Ven­rock joins the biotech VC fundrais­ing game, toss­ing $447M in­to a $4.3B pot of new mon­ey

It’s not un­usu­al to find the part­ners at Ven­rock trav­el­ing in the A-list sec­tion of biotech. They like to find some of the more ma­ture star­tups head­ed to­ward IPOs or some new ar­rivals on the pub­lic mar­ket — stick­ing with deep-pock­et in­vestors look­ing to do big things. And they clear­ly have a big ap­petite for rounds that can range up in­to the stratos­phere.

It looks like they’re go­ing to re­main in that neigh­bor­hood for some time to come.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER